Oncoland Limited - Accounts to registrar (filleted) - small 23.2.5

Oncoland Limited - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v23.2.0.158 00865608 Board of Directors 1.1.22 31.12.22 31.12.22 false true false false true false Fair value model Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure008656082021-12-31008656082022-12-31008656082022-01-012022-12-31008656082020-12-31008656082021-01-012021-12-31008656082021-12-3100865608ns16:EnglandWales2022-01-012022-12-3100865608ns15:PoundSterling2022-01-012022-12-3100865608ns11:Director12022-01-012022-12-3100865608ns11:PrivateLimitedCompanyLtd2022-01-012022-12-3100865608ns11:SmallEntities2022-01-012022-12-3100865608ns11:AuditExempt-NoAccountantsReport2022-01-012022-12-3100865608ns11:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3100865608ns11:SmallCompaniesRegimeForAccounts2022-01-012022-12-3100865608ns11:FullAccounts2022-01-012022-12-3100865608ns11:OrdinaryShareClass12022-01-012022-12-3100865608ns11:OrdinaryShareClass22022-01-012022-12-3100865608ns11:Director22022-01-012022-12-3100865608ns11:Director32022-01-012022-12-3100865608ns11:Director42022-01-012022-12-3100865608ns11:CompanySecretary12022-01-012022-12-3100865608ns11:RegisteredOffice2022-01-012022-12-3100865608ns6:CurrentFinancialInstruments2022-12-3100865608ns6:CurrentFinancialInstruments2021-12-3100865608ns6:Non-currentFinancialInstruments2022-12-3100865608ns6:Non-currentFinancialInstruments2021-12-3100865608ns6:ShareCapital2022-12-3100865608ns6:ShareCapital2021-12-3100865608ns6:RevaluationReserve2022-12-3100865608ns6:RevaluationReserve2021-12-3100865608ns6:CapitalRedemptionReserve2022-12-3100865608ns6:CapitalRedemptionReserve2021-12-3100865608ns6:FurtherSpecificReserve3ComponentTotalEquity2022-12-3100865608ns6:FurtherSpecificReserve3ComponentTotalEquity2021-12-3100865608ns6:RetainedEarningsAccumulatedLosses2022-12-3100865608ns6:RetainedEarningsAccumulatedLosses2021-12-3100865608ns6:LandBuildings2021-12-3100865608ns6:PlantMachinery2021-12-3100865608ns6:LandBuildings2022-01-012022-12-3100865608ns6:PlantMachinery2022-01-012022-12-3100865608ns6:LandBuildings2022-12-3100865608ns6:PlantMachinery2022-12-3100865608ns6:LandBuildings2021-12-3100865608ns6:PlantMachinery2021-12-3100865608ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2021-12-3100865608ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2022-01-012022-12-3100865608ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2022-12-3100865608ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2021-12-3100865608ns6:WithinOneYearns6:CurrentFinancialInstruments2022-12-3100865608ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3100865608ns6:AfterOneYearns6:Non-currentFinancialInstruments2022-12-3100865608ns6:AfterOneYearns6:Non-currentFinancialInstruments2021-12-3100865608ns6:Secured2022-12-3100865608ns6:Secured2021-12-3100865608ns6:AcceleratedTaxDepreciationDeferredTax2022-12-3100865608ns6:AcceleratedTaxDepreciationDeferredTax2021-12-3100865608ns6:DeferredTaxation2021-12-3100865608ns6:DeferredTaxation2022-01-012022-12-3100865608ns6:DeferredTaxation2022-12-3100865608ns11:OrdinaryShareClass12022-12-3100865608ns11:OrdinaryShareClass22022-12-3100865608ns6:RetainedEarningsAccumulatedLosses2021-12-3100865608ns6:RevaluationReserve2021-12-3100865608ns6:CapitalRedemptionReserve2021-12-3100865608ns6:FurtherSpecificReserve3ComponentTotalEquity2021-12-3100865608ns6:RetainedEarningsAccumulatedLosses2022-01-012022-12-31
REGISTERED NUMBER: 00865608 (England and Wales)















Financial Statements

for the Year Ended 31 December 2022

for

Oncoland Limited

Oncoland Limited (Registered number: 00865608)






Contents of the Financial Statements
for the Year Ended 31 December 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Oncoland Limited

Company Information
for the Year Ended 31 December 2022







DIRECTORS: A J Billings
C J Billings
R J Billings
S J Billings





SECRETARY: S J Billings





REGISTERED OFFICE: Gay Dawn Offices
Pennis Lane
Fawkham
Longfield
Kent
DA3 8LY





REGISTERED NUMBER: 00865608 (England and Wales)






Oncoland Limited (Registered number: 00865608)

Balance Sheet
31 December 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 12,538,027 12,067,029
Investments 5 4 4
Investment property 6 12,400,000 13,650,000
24,938,031 25,717,033

CURRENT ASSETS
Inventories 1,343,085 1,369,550
Debtors 7 1,126,296 1,386,698
Cash at bank and in hand 198,799 5,708
2,668,180 2,761,956
CREDITORS
Amounts falling due within one year 8 8,436,570 9,571,143
NET CURRENT LIABILITIES (5,768,390 ) (6,809,187 )
TOTAL ASSETS LESS CURRENT LIABILITIES 19,169,641 18,907,846

CREDITORS
Amounts falling due after more than one
year

9

(2,112,033

)

(2,250,905

)

PROVISIONS FOR LIABILITIES 11 (1,224,066 ) (1,057,706 )
NET ASSETS 15,833,542 15,599,235

CAPITAL AND RESERVES
Called up share capital 12 573,432 573,432
Revaluation reserve 13 8,313,951 7,803,248
Capital redemption reserve 13 26,572 26,572
Fair value reserve 13 3,327,216 4,183,173
Retained earnings 13 3,592,371 3,012,810
SHAREHOLDERS' FUNDS 15,833,542 15,599,235

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Oncoland Limited (Registered number: 00865608)

Balance Sheet - continued
31 December 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2023 and were signed on its behalf by:





A J Billings - Director


Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements
for the Year Ended 31 December 2022

1. STATUTORY INFORMATION

Oncoland Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Land is stated at fair value however it is not being depreciated as it has an unlimited life.

Buildings, plant and machinery etc are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Buildings 4% on reducing balance basis
Plant and machinery etc 5%-25% on reducing balance basis
Land Not depreciated

Investment property
In accordance with the requirements of FRS 102 properties which are considered to be held to earn rentals or for capital appreciation or both have been reclassified as investment properties at 1January 2015, the FRS 102 transition date.

The company carries its investment property at fair value, with changes in fair value being recognised in profit or loss. The fair value at 31 December 2022 of the properties has been determined by the directors of the company. The directors have adopted a valuation model based upon a multiple of the gross rental income adjusted where appropriate for any individual property market considerations. The directors over-ride their valuation model where independent valuation specialists have been engaged.

Inventories
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Property, plant and equipment acquired under finance leases or hire purchase contracts are capitalised and depreciated in the same manner as other tangible fixed assets. The related obligations, net of future finance charges, are included in creditors.

Government grants
The company is in receipt of monies from the Government in the form of the Single Payment Scheme and monies received are recognised in the year of claim.

Fixed asset investments
Investments in shares are accounted for at cost less accumulated impairment losses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2021 - 11 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST OR VALUATION
At 1 January 2022 11,568,508 3,639,664 15,208,172
Additions 8,500 149,450 157,950
Disposals - (45,750 ) (45,750 )
Revaluations 663,601 - 663,601
At 31 December 2022 12,240,609 3,743,364 15,983,973
DEPRECIATION
At 1 January 2022 1,093,152 2,047,991 3,141,143
Charge for year 84,494 253,752 338,246
Eliminated on disposal - (33,443 ) (33,443 )
At 31 December 2022 1,177,646 2,268,300 3,445,946
NET BOOK VALUE
At 31 December 2022 11,062,963 1,475,064 12,538,027
At 31 December 2021 10,475,356 1,591,673 12,067,029

Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

4. PROPERTY, PLANT AND EQUIPMENT - continued

Cost or valuation at 31 December 2022 is represented by:

Plant and
Land and machinery
buildings etc Totals
£    £    £   
Valuation in 2013 5,188,254 - 5,188,254
Valuation in 2014 532,472 - 532,472
Valuation in 2015 1,386,271 - 1,386,271
Valuation in 2019 758,730 - 758,730
Valuation in 2022 663,601 - 663,601
Cost 3,711,281 3,743,364 7,454,645
12,240,609 3,743,364 15,983,973

If land and buildings had not been revalued they would have been included at the following historical cost:

2022 2021
£    £   
Cost 3,214,008 3,205,507
Aggregate depreciation 1,177,647 1,093,152

Value of land in freehold land and buildings 487,273 487,273

Land and buildings were valued on a fair value basis on 31 December 2022 by the directors .

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST OR VALUATION
At 1 January 2022 1,396,820
Additions 116,464
Transfer to ownership (819,031 )
At 31 December 2022 694,253
DEPRECIATION
At 1 January 2022 512,832
Charge for year 73,043
Transfer to ownership (383,182 )
At 31 December 2022 202,693
NET BOOK VALUE
At 31 December 2022 491,560
At 31 December 2021 883,988

Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

5. FIXED ASSET INVESTMENTS
Interest
in other
Investments
£   
COST
At 1 January 2022
and 31 December 2022 125,698
PROVISIONS
At 1 January 2022
and 31 December 2022 125,694
NET BOOK VALUE
At 31 December 2022 4
At 31 December 2021 4

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 January 2022 13,650,000
Disposals (700,000 )
Revaluations (550,000 )
At 31 December 2022 12,400,000
NET BOOK VALUE
At 31 December 2022 12,400,000
At 31 December 2021 13,650,000

Investment properties are stated in the balance sheet at their aggregate fair value based on valuations carried out at 31 December 2022 by the directors. If investment property had not been revalued it would have been included at the historical cost of £ £8,169,731 (2021- £ 8,599,391).

7. DEBTORS
2022 2021
£    £   
Amounts falling due within one year:
Trade debtors 186,817 101,320
Amounts owed by group undertakings 230,694 -
Other debtors 708,785 1,284,698
1,126,296 1,386,018

Amounts falling due after more than one year:
Other debtors - 680

Aggregate amounts 1,126,296 1,386,698

Included in other debtors is a deferred tax asset of £97,644 (2021 - £97,644).

Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Bank loans and overdrafts 7,643,304 8,329,416
Hire purchase contracts 120,846 266,849
Trade creditors 412,576 339,559
Amounts owed to group undertakings - 196,806
Taxation and social security 66,259 42,608
Other creditors 193,585 395,905
8,436,570 9,571,143

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2022 2021
£    £   
Bank loans and overdrafts 2,055,244 2,160,941
Hire purchase contracts 56,789 89,964
2,112,033 2,250,905

Amounts falling due in more than five years:

Repayable by instalments
Bank loans 1,829,153 1,931,545

10. SECURED DEBTS

The following secured debts are included within creditors:

2022 2021
£    £   
Bank loans and overdrafts 9,698,548 10,490,357
Hire purchase contracts 177,635 356,813
9,876,183 10,847,170

Nature of Security
The hire purchase contracts are secured by the financed assets.

Bank loans are secured by legal charge over company's properties and guarantees given by F.C. Stark Limited, Oncoland Energy Limited and personal guarantees from the directors.

11. PROVISIONS FOR LIABILITIES
2022 2021
£    £   
Deferred tax
Accelerated capital allowances 105,637 127,793
Unrealised surplus on
revaluation of investment
properties 903,052 867,434
Unrealised surplus on
revaluation of
trading properties 215,377 62,479
1,224,066 1,057,706

Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

11. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 January 2022 1,057,706
Provided during year 13,462
Charge to other comprehensive 152,898
income
Balance at 31 December 2022 1,224,066

12. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 2022 2021
value: £    £   
234,000 Ordinary A £1 234,000 234,000
339,432 Ordinary B £1 339,432 339,432
573,432 573,432

13. RESERVES
Capital Fair
Retained Revaluation redemption value
earnings reserve reserve reserve Totals
£    £    £    £    £   

At 1 January 2022 3,012,810 7,803,248 26,572 4,183,173 15,025,803
Deficit for the year (276,396 ) (276,396 )
Transfer deferred tax on
investment property 35,618 - - (35,618 ) -
Surplus on transfer 270,339 - - (270,339 ) -
Revaluation of
land and buildings - 663,601 - - 663,601
Transfer revaluation on
investment property 550,000 - - (550,000 ) -
Deferred tax on trading
property - (152,898 ) - - (152,898 )
At 31 December 2022 3,592,371 8,313,951 26,572 3,327,216 15,260,110

14. CONTINGENT LIABILITIES

C Hoare & Co
The company is a guarantor to a guarantee limited to £4,430,000 plus interest and charges provided to C Hoare & Co in respect of the bank borrowing of F.C. Stark Limited, the company's parent company, supported by legal charge over company property.

15. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Oncoland Limited (Registered number: 00865608)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

15. RELATED PARTY DISCLOSURES - continued

Watchingwell Farms Limited
Subsidiary (not exempt)

The company made sales of goods and services to Watchingwell Farms Limited of £1,084,145 (2021 - £
1,640,466)
The company purchased goods and services totalling £114,423 (2021- £114,133) from Watchingwell Farms Limited.

16. PARENT COMPANY

The parent company is F.C. Stark Limited.